Evidence map›Paper›PMID 32638003›Full record

Observational studyClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Extravascular Dermal Trypanosomes in Suspected and Confirmed Cases of gambiense Human African Trypanosomiasis.

Mariame Camara, Alseny M'mah Soumah, Hamidou Ilboudo, Christelle Travaillé, Caroline Clucas, Anneli Cooper, Nono-Raymond Kuispond Swar, Oumou Camara, Ibrahim Sadissou, Estefania Calvo Alvarez and 7 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Evasive mechanisms of human VSG and PfEMP1 antigens with link to Vaccine scenario: a review.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2025
    Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 5 countries.

Mariame CamaraProgramme National de Lutte Contre la Trypanosomiase Humaine Africaine, Ministère de la Santé, Conakry, Guinea.
Alseny M'mah SoumahProgramme National de Lutte Contre la Trypanosomiase Humaine Africaine, Ministère de la Santé, Conakry, Guinea.
Hamidou IlboudoProgramme National de Lutte Contre la Trypanosomiase Humaine Africaine, Ministère de la Santé, Conakry, Guinea.
Christelle TravailléTrypanosome Transmission Group, Trypanosome Cell Biology Unit, Institut National de la Santé et de la Recherche Médicale (INSERM) U1201 and Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
Caroline ClucasWellcome Centre for Integrative Parasitology, College of Medical, Veterinary, and Life Sciences, Henry Wellcome Building for Comparative Medical Sciences, Glasgow, Scotland, United Kingdom.
Anneli CooperWellcome Centre for Integrative Parasitology, College of Medical, Veterinary, and Life Sciences, Henry Wellcome Building for Comparative Medical Sciences, Glasgow, Scotland, United Kingdom.
Nono-Raymond Kuispond SwarWellcome Centre for Integrative Parasitology, College of Medical, Veterinary, and Life Sciences, Henry Wellcome Building for Comparative Medical Sciences, Glasgow, Scotland, United Kingdom.
Oumou CamaraProgramme National de Lutte Contre la Trypanosomiase Humaine Africaine, Ministère de la Santé, Conakry, Guinea.
Ibrahim SadissouInstitut de Recherche pour le Développement, Unité Mixte de Recherche Institut de Recherche pour le Développement (IRD)-CIRAD 177 InterTryp, Campus International de Baillarguet, Montpellier, France.
Estefania Calvo AlvarezTrypanosome Transmission Group, Trypanosome Cell Biology Unit, Institut National de la Santé et de la Recherche Médicale (INSERM) U1201 and Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
Aline CrouzolsTrypanosome Transmission Group, Trypanosome Cell Biology Unit, Institut National de la Santé et de la Recherche Médicale (INSERM) U1201 and Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.
Jean-Mathieu BartInstitut de Recherche pour le Développement, Unité Mixte de Recherche Institut de Recherche pour le Développement (IRD)-CIRAD 177 InterTryp, Campus International de Baillarguet, Montpellier, France.
Vincent JamonneauInstitut de Recherche pour le Développement, Unité Mixte de Recherche Institut de Recherche pour le Développement (IRD)-CIRAD 177 InterTryp, Campus International de Baillarguet, Montpellier, France.
Mamadou CamaraProgramme National de Lutte Contre la Trypanosomiase Humaine Africaine, Ministère de la Santé, Conakry, Guinea.
Annette MacLeodWellcome Centre for Integrative Parasitology, College of Medical, Veterinary, and Life Sciences, Henry Wellcome Building for Comparative Medical Sciences, Glasgow, Scotland, United Kingdom.
Bruno BuchetonProgramme National de Lutte Contre la Trypanosomiase Humaine Africaine, Ministère de la Santé, Conakry, Guinea.
Brice RotureauTrypanosome Transmission Group, Trypanosome Cell Biology Unit, Institut National de la Santé et de la Recherche Médicale (INSERM) U1201 and Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France.ORCID 0000-0003-0671-8999
Centre de Coopération Internationale en Recherche Agronomique pour le Développement · FRInserm · FRWellcome Centre for Molecular Parasitology · GBDonka Hospital · GN

Funding

Wellcome Trust 209511/Z/17/Z
6 · The paper itself

Abstract

backgroundThe diagnosis of gambiense human African trypanosomiasis (gHAT) typically involves 2 steps: a serological screen, followed by the detection of living trypanosome parasites in the blood or lymph node aspirate. Live parasites can, however, remain undetected in some seropositive individuals, who, we hypothesize, are infected with Trypanosoma brucei gambiense parasites in their extravascular dermis.

methodsTo test this hypothesis, we conducted a prospective observational cohort study in the gHAT focus of Forecariah, Republic of Guinea. Of the 5417 subjects serologically screened for gHAT, 66 were enrolled into our study and underwent a dermatological examination. At enrollment, 11 seronegative, 8 unconfirmed seropositive, and 18 confirmed seropositive individuals had blood samples and skin biopsies taken and examined for trypanosomes by molecular and immunohistological methods.

resultsIn seropositive individuals, dermatological symptoms were significantly more frequent, relative to seronegative controls. T.b. gambiense parasites were present in the blood of all confirmed cases (n = 18) but not in unconfirmed seropositive individuals (n = 8). However, T. brucei parasites were detected in the extravascular dermis of all unconfirmed seropositive individuals and all confirmed cases. Skin biopsies of all treated cases and most seropositive untreated individuals progressively became negative for trypanosomes 6 and 20 months later.

conclusionsOur results highlight the skin as a potential reservoir for African trypanosomes, with implications for our understanding of this disease's epidemiology in the context of its planned elimination and underlining the skin as a novel target for gHAT diagnostics.

Indexed as

Trypanosomiasis, AfricanAnimalsGuineaHumansProspective StudiesTrypanosoma brucei gambiensehuman African trypanosomiasisreservoirskinTrypanosoma brucei gambiense

Identifiers

PMID32638003
PMCPMC8246823
OpenAlexW3041328141

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.